SmartKem, Inc. (SMTK)
NASDAQ: SMTK · Real-Time Price · USD
2.260
-0.110 (-4.64%)
At close: May 2, 2025, 4:00 PM
2.390
+0.130 (5.75%)
After-hours: May 2, 2025, 7:03 PM EDT
Company Description
SmartKem, Inc., together with its subsidiaries, develops in-house the materials necessary to fabricate OTFT devices.
It provides TRUFLEX semiconductor polymers which enable low temperature printing processes that are compatible with existing manufacturing infrastructure to deliver low-cost displays.
The company offers electronic polymer platform is used in display technologies, such as MicroLED, miniLED and AMOLED, as well as in applications in advanced chip packaging, sensors, and logic.
It also provides prototypes for customers. SmartKem, Inc. was founded in 2009 and is headquartered in Manchester, the United Kingdom.
SmartKem, Inc.
Country | United Kingdom |
Founded | 2009 |
Industry | Semiconductor Equipment & Materials |
Sector | Technology |
Employees | 29 |
CEO | Ian Jenks |
Contact Details
Address: Manchester Technology Centre, Hexagon Tower Manchester, M9 8GQ United Kingdom | |
Phone | 44 16 1721 1514 |
Website | smartkem.com |
Stock Details
Ticker Symbol | SMTK |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001817760 |
CUSIP Number | 83193D104 |
ISIN Number | US83193D2036 |
Employer ID | 85-1083654 |
SIC Code | 3674 |
Key Executives
Name | Position |
---|---|
Ian Tudor Jenks | Chairman of the Board, President and Chief Executive Officer |
Barbra C. Keck M.B.A. | Chief Financial Officer |
Dr. Simon Ogier Ph.D. | Chief Technology Officer |
Jonathan Watkins | Chief Operating Officer |
Dr. Beverley Brown Ph.D. | Chief Scientist |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 29, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Apr 28, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Apr 23, 2025 | ARS | Filing |
Apr 23, 2025 | DEF 14A | Other definitive proxy statements |
Apr 22, 2025 | 8-K | Current Report |
Apr 8, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Apr 4, 2025 | 8-K | Current Report |
Apr 1, 2025 | 8-K | Current Report |
Mar 31, 2025 | SCHEDULE 13G | Filing |
Mar 31, 2025 | 10-K | Annual Report |